Delivery Order SPE2DB22D2206-SPE2DB25FJL76
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency awarded a $1,810.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count), a prescription weight management medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of QSYMIA 15 mg-92 mg capsules (30-count units) with a firm fixed price ceiling value of $1,643.28. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,646.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under contract 4569035131. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and...
- This delivery order, valued at $3,309.69, was awarded on September 8, 2025, to AmerisourceBergen Drug Corp for the supply of QSYMIA 7.5MG-46MG 30S, a pharmaceutical product used in weight management treatment. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection among eligible vendors. The contract will be completed by September 9, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain, which supports...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,013.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $1,225.31 on June 5, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules (30-count package). This is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Qsymia 15mg-92mg in 30-count packages, with a ceiling value of $2,738.80. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is performable in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025, and represents a child delivery order under a larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJL76Delivery Order
The Defense Logistics Agency awarded a $1,547.92 delivery order to AmerisourceBergen Drug Corp for QSYMIA 7.5 MG-46 MG capsules (30-count units), a pharmaceutical product used in weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/18/25 |